ArticleBlood2026

Circulating tumor cells in myeloma are a compound biomarker for bone marrow high-risk genomic alterations and tumor load.

Cathelijne Fokkema et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.